Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Polaryx Therapeutics, Inc. - Common Stock
(NQ:
PLYX
)
2.470
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Polaryx Therapeutics, Inc. - Common Stock
What's Going On With Polaryx Therapeutics Stock Wednesday?
↗
February 18, 2026
Polaryx Therapeutics Inc. (NASDAQ: PLYX) stock fell after a surge due to a major clinical development announcement.
Via
Benzinga
Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans
↗
February 17, 2026
Polaryx Therapeutics (NASDAQ: PLYX) shares rise on selecting research organization for SOTERIA trial to evaluate lead candidate for lysosomal storage disorders.
Via
Benzinga
Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial
February 17, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
February 10, 2026
Oral presentation highlighted the effect of gemfibrozil on Krabbe disease, one of four LSDs in the upcoming Phase 2 SOTERIA basket trial evaluating PLX-200 (reformulated gemfibrozil)
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Therapeutics Welcomes New Members of the Board of Directors
February 05, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch
February 03, 2026
Oral presentation provides additional scientific rationale on Krabbe disease, one of four LSDs in the Phase 2 SOTERIA basket trial designed to evaluate the safety and clinical activity of lead drug...
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.